Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;22(3):e134-8.
doi: 10.3747/co.22.2252.

Cancer care burden: aiming at the Achilles heel

Affiliations

Cancer care burden: aiming at the Achilles heel

S Ahmed et al. Curr Oncol. 2015 Jun.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Proposed framework to reduce cancer care costs in the short and long term. The cost of cancer care has risen exponentially, with the major contributing factors being the mounting rates of new cancers, the escalating prices of novel cancer therapies, the emergence of high-cost innovations and technologies, and overutilization and futile disease-directed care. A combination of top-down and bottom-up approaches involving value-based and evidence-informed care, shared decision-making, innovative research, transformed policies, and a focus on environmental and social determinants of health are required to overturn the rising costs.

References

    1. Stewart BW, Wild CP, editors. The global and regional burden of cancer. World Cancer Report 2014. Lyon, France: IARC Press; 2015. pp. 16–24.
    1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics . Canadian Cancer Statistics 2014. Toronto, ON: Canadian Cancer Society; 2014. [Available online at: http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20...; cited 6 April 2015]
    1. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933–80. doi: 10.1016/S1470-2045(11)70141-3. - DOI - PubMed
    1. Hillner BE, Smith TJ. Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. J Clin Oncol. 2009;27:2111–13. doi: 10.1200/JCO.2008.21.0534. - DOI - PubMed
    1. Canadian Cancer Society Cancer Drug Access for Canadians Toronto, ON: Canadian Cancer Society; 2009[Available online at: http://www.colorectal-cancer.ca/IMG/pdf/cancer_drug_access_report_en.pdfcited 1 November 2014]

LinkOut - more resources